Investigation Overview
August 31, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Array Biopharma Inc (NASDAQ:ARRY) was announced over potential breaches of fiduciary duties by certain officers and directors at Array Biopharma Inc. The investigation by a law firm concerns whether certain Array Biopharma directors breached their fiduciary duties and ca...
You must register (for free) or login to view the entire investigation.